Glatt Pharmaceutical Services is an oral solids CDMO specializes in the formulation development and process optimization of hard to craft formulations and challenging modified release profiles. Glatt's core technologies include solubility enhancement via production of ASDs using fluid bed technology, taste masking, and complex multi-particulate dosage forms. Glatt offers large scale solvent processing and handles DEA substances schedule l through V.